Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (3): 240-247.doi: 10.3969/j.issn.1000-6621.2021.03.009
• Original Articles • Previous Articles Next Articles
RAO Li-xin, XIAO Xiao, CHEN Jing, SHEN Xin(), JIANG Qing-wu()
Received:
2021-01-26
Online:
2021-03-10
Published:
2021-03-03
Contact:
SHEN Xin,JIANG Qing-wu
E-mail:shenxin@scdc.sh.cn;jiangqw@fudan.edu.cn
RAO Li-xin, XIAO Xiao, CHEN Jing, SHEN Xin, JIANG Qing-wu. Study of screening methods of MTB/HIV co-infected patients in low TB and AIDS prevalence area[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 240-247. doi: 10.3969/j.issn.1000-6621.2021.03.009
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.03.009
年份 | 结核病患者 (例) | 结核病患者接受HIV抗体检测 | 结核病患者HIV抗体检测阳性 | 结核病患者新确诊HIV感染 | ||||
---|---|---|---|---|---|---|---|---|
例数 | 率(%) | 例数 | 率(%) | 例数 | 率(%) | |||
2012 | 8 227 | 1 322 | 16.07 | 32 | 2.42 | 3 | 0.23 | |
2013 | 8 318 | 2 128 | 25.58 | 31 | 1.46 | 7 | 0.33 | |
2014 | 8 267 | 4 087 | 49.44 | 56 | 1.37 | 14 | 0.34 | |
2015 | 7 776 | 4 595 | 59.09 | 36 | 0.78 | 16 | 0.35 | |
2016 | 7 805 | 4 304 | 55.14 | 42 | 0.98 | 10 | 0.23 | |
2017 | 7 321 | 4 327 | 59.10 | 37 | 0.86 | 5 | 0.12 | |
2018 | 7 397 | 4 378 | 59.19 | 34 | 0.78 | 4 | 0.09 | |
2019 | 6 796 | 4 529 | 66.64 | 20 | 0.44 | 2 | 0.04 | |
2020 | 6 248 | 3 995 | 63.94 | 20 | 0.50 | 3 | 0.08 | |
合计 | 68155 | 33 665 | 49.39 | 308 | 0.91 | 64 | 0.19 |
特征 | 例数 | 构成比(%) | 特征 | 例数 | 构成比(%) |
---|---|---|---|---|---|
性别 | 职业 | ||||
男 | 284 | 92.21 | 工人 | 107 | 34.74 |
女 | 24 | 7.79 | 离退人员 | 75 | 24.35 |
年龄组(岁) | 家政、家务及待业 | 50 | 16.23 | ||
0~25 | 22 | 7.14 | 其他c | 76 | 24.68 |
26~35 | 77 | 25.00 | 来源地 | ||
36~45 | 62 | 20.13 | 上海 | 211 | 68.51 |
46~55 | 60 | 19.48 | 江苏 | 24 | 7.79 |
56~65 | 54 | 17.53 | 安徽 | 21 | 6.82 |
66~75 | 27 | 8.77 | 浙江 | 7 | 2.27 |
76~85 | 6 | 1.95 | 四川 | 7 | 2.27 |
病原学结果a | 黑龙江 | 7 | 2.27 | ||
阳性 | 134 | 46.53 | 其他省份 | 31 | 10.07 |
阴性或未查 | 154 | 53.47 | 并发肺外结核d | ||
治疗成功b | 否 | 274 | 92.88 | ||
是 | 219 | 78.49 | 是 | 21 | 7.12 |
否 | 60 | 21.51 | 并发糖尿病 | ||
在抗结核治疗过程中死亡b | 否 | 301 | 97.73 | ||
否 | 246 | 88.17 | 是 | 7 | 2.27 |
是 | 33 | 11.83 | CD4+ T淋巴细胞计数(个/μl)e | ||
转入耐多药治疗 | <200 | 62 | 70.45 | ||
否 | 307 | 99.68 | 200~399 | 20 | 22.73 |
是 | 1 | 0.32 | ≥400 | 6 | 6.82 |
因素 | HIV阳性(69例) | HIV阴性(10700例) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
例数 | 构成比(%) | 例数 | 构成比(%) | |||
性别 | 17.882 | <0.001 | ||||
男 | 63 | 0.87 | 7211 | 99.13 | ||
女 | 6 | 0.17 | 3489 | 99.83 | ||
年龄组(岁) | 18.319 | 0.005 | ||||
0~25 | 4 | 0.18 | 2252 | 99.82 | ||
26~35 | 21 | 0.80 | 2596 | 99.20 | ||
36~45 | 14 | 1.13 | 1230 | 98.87 | ||
46~55 | 11 | 0.89 | 1227 | 99.11 | ||
56~65 | 12 | 0.75 | 1590 | 99.25 | ||
66~75 | 6 | 0.61 | 974 | 99.39 | ||
76~85 | 1 | 0.12 | 831 | 99.88 | ||
民族 | 0.533 | 0.465 | ||||
汉族 | 69 | 0.65 | 10618 | 99.35 | ||
少数民族 | 0 | 0.00 | 82 | 100.00 | ||
来源地 | 3.477 | 0.062 | ||||
上海市 | 46 | 0.77 | 5936 | 99.23 | ||
其他省份 | 23 | 0.48 | 4764 | 99.52 | ||
病原学结果a | 0.302 | 0.584 | ||||
阳性 | 30 | 0.72 | 4125 | 99.28 | ||
阴性或未查 | 38 | 0.63 | 5978 | 99.37 | ||
治疗成功 | 17.302 | <0.001 | ||||
是 | 56 | 0.56 | 10011 | 99.44 | ||
否 | 13 | 1.85 | 689 | 98.15 | ||
在抗结核治疗过程中死亡 | 47.647 | <0.001 | ||||
否 | 58 | 0.55 | 10426 | 99.45 | ||
是 | 11 | 3.86 | 274 | 96.14 | ||
并发肺外结核 | 9.944 | 0.002 | ||||
否 | 61 | 0.59 | 10267 | 99.41 | ||
是 | 8 | 1.81 | 433 | 98.19 | ||
并发糖尿病 | 2.146 | 0.143 | ||||
否 | 67 | 0.67 | 9890 | 99.33 | ||
是 | 2 | 0.25 | 810 | 99.75 | ||
转入耐多药治疗 | 0.921 | 0.337 | ||||
是 | 0 | 0.00 | 141 | 100.00 | ||
否 | 69 | 0.65 | 10559 | 99.35 |
影响因素 | β值 | s | Wald χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
性别 | |||||
女 | 1.000 | ||||
男 | 1.684 | 0.433 | 15.133 | <0.001 | 5.386(2.306~12.581) |
年龄组(岁) | |||||
0~25 | 1.000 | ||||
26~35 | 1.735 | 1.161 | 2.233 | 0.135 | 5.669(0.582~55.197) |
36~45 | 3.267 | 1.069 | 9.344 | 0.002 | 26.243(3.230~213.244) |
46~55 | 3.488 | 1.073 | 10.562 | 0.001 | 32.736(3.993~268.358) |
56~65 | 3.011 | 1.072 | 7.884 | 0.005 | 20.309(2.482~166.144) |
66~75 | 2.600 | 1.058 | 6.038 | 0.014 | 13.461(1.692~107.059) |
76~85 | 2.009 | 1.088 | 3.409 | 0.065 | 7.454(0.884~62.868) |
来源地 | |||||
其他省份 | 1.000 | ||||
上海市 | 0.557 | 0.286 | 3.786 | 0.052 | 1.745(0.996~3.056) |
成功治疗 | |||||
否 | 1.000 | ||||
是 | 0.216 | 0.715 | 0.091 | 0.762 | 1.241(0.306~5.038) |
在抗结核治疗过程中死亡 | |||||
否 | 1.000 | ||||
是 | 2.700 | 0.785 | 11.822 | 0.001 | 14.875(3.192~69.312) |
并发肺外结核 | |||||
否 | 1.000 | ||||
是 | 1.239 | 0.390 | 10.097 | 0.001 | 3.451(1.607~7.409) |
并发糖尿病 | |||||
否 | 1.000 | ||||
是 | -1.336 | 0.728 | 3.364 | 0.067 | 0.263(0.063~1.096) |
年度 | 新确诊 HIV感染 者(例) | 既往 HIV 感染者 (例) | 累积 HIV 感染者 (例) | 接受胸部 影像学检 查或痰检 者(例) | 结核病 检查率 (%) | 新确诊 HIV感染 者诊断结 核病例数 | 新确诊 HIV感 染者结核 病诊断率 (%) | 既往HIV 感染者 诊断结核 病例数 | 既往HIV 感染者结 核病诊断 率(%) | 诊断 结核病 患者例数 合计 | HIV感染 者中结核 病确诊率 (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2012 | 1756 | 3156 | 4912 | 3193 | 65.00 | 26 | 1.48 | 24 | 0.76 | 50 | 1.02 |
2013 | 1925 | 3904 | 5829 | 2836 | 48.65 | 16 | 0.83 | 17 | 0.44 | 33 | 0.57 |
2014 | 1912 | 5265 | 7177 | 3029 | 42.20 | 32 | 1.67 | 27 | 0.51 | 59 | 0.82 |
2015 | 1945 | 6159 | 8104 | 5459 | 67.36 | 10 | 0.51 | 15 | 0.24 | 25 | 0.31 |
2016 | 1942 | 6748 | 8690 | 7254 | 83.48 | 20 | 1.03 | 15 | 0.22 | 35 | 0.40 |
2017 | 1514 | 7579 | 9093 | 7424 | 81.65 | 23 | 1.52 | 20 | 0.26 | 43 | 0.47 |
2018 | 1716 | 8407 | 10123 | 9845 | 97.25 | 17 | 0.99 | 27 | 0.32 | 44 | 0.43 |
2019 | 1573 | 9452 | 11025 | 10661 | 96.70 | 13 | 0.83 | 18 | 0.19 | 31 | 0.28 |
2020 | 1148 | 10730 | 11878 | 10424 | 87.76 | 5 | 0.44 | 20 | 0.19 | 25 | 0.21 |
[1] | World Health Organization. WHO Policy on Collaborative TB/HIV Activities: Guidelines for National Programmes and Other Stakeholders. Geneva: World Health Organization, 2012. |
[2] | 徐飚. 聚焦结核感染预防和传播控制争取实现终止结核病流行目标. 上海预防医学, 2018,30(3):161-162. doi: 10.19428/j.cnki.sjpm.2018.18665. |
[3] | 中国疾病预防控制中心结核病预防控制中心. 2019年中国结核病监测报告. 北京: 中国疾病预防控制中心结核病预防控制中心, 2020. |
[4] | World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization, 2020. |
[5] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 2017-11-09. |
[6] | 中华医学会感染病学分会艾滋病学组, 中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识. 中华临床感染病杂志, 2017,10(2):81-90. doi: 10.3760/cma.j.issn.1674-2397.2017.02.001. |
[7] |
Ford N, Matteelli A, Shubber Z, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc, 2016,19(1):20714. doi: 10.7448/IAS.19.1.20714.
URL pmid: 26765347 |
[8] | 李涛, 成诗明, 杜昕, 等. 对Mtb与HIV双重感染防治重点县(区)结核病患者进行HIV检测的效果分析. 中国防痨杂志, 2013,35(11):905-909. |
[9] | 赖钰基, 成诗明, 周林, 等. 不同艾滋病流行地区结核病患者HIV筛查效果分析. 中国防痨杂志, 2015,37(1):9-13. doi: 10.3969/j.issn.1000-6621.2015.01.003. |
[10] | 肖月, 夏岚, 宋杨, 等. 四川省结核分枝杆菌与HIV双重感染防治重点区县患者发现效果评价. 寄生虫病与感染性疾病, 2019,17(4):204-208. doi: CNKI:SUN:SJCB.0.2019-04-004. |
[11] | 林定文, 崔哲哲, 刘飞鹰, 等. 广西TB/HIV双重感染筛查与诊疗管理现况分析. 重庆医学, 2017,46(35):4987-4990. doi: 10.3969/j.issn.1671-8348.2017.35.028. |
[12] | 李月华, 吴刚, 马依夏提·马合木提. 新疆第五轮全球基金结核病/艾滋病双重感染防治项目效果评价. 中国防痨杂志, 2010,32(11):767-769. |
[13] | 李银萍, 范月玲, 高建伟. 山西省结核分枝杆菌与人类免疫缺陷病毒双重感染防治效果分析. 中国药物与临床, 2019,19(6):914-916. doi: 10.11655/zgywylc2019.06.023. |
[14] | 张鑫, 樊辰霞, 高雨龙, 等. 2010—2018年内蒙古自治区TB/HIV双重感染患者筛查与治疗情况分析. 现代预防医学, 2020,47(7):1315-1317. doi: CNKI:SUN:XDYF.0.2020-07-042. |
[15] | 成诗明, 周林, 刘二勇, 等. 结核分枝杆菌和艾滋病病毒双重感染防治合作模式与效果. 中国防痨杂志, 2011,33(7):416-421. |
[1] | MA Yan, GAO Wei-wei. Pay attention to the reasonable treatment of retreatment tuberculosis:today is not what it used to be [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 313-317. |
[2] | DENG Guo-fang. Interpretation of Expert consensus on treatment and management of tuberculosis-diabetes mellitus comorbidity [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 318-321. |
[3] | SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei. Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327. |
[4] | GE Qi-ping, DU Jian, SHU Wei, MA Yan, MA Li-ping, ZHAO Cai-yan, CHEN Yu-hui, ZHANG Li-jie, HUANG Xue-rui, HAN Xi-qin, CHEN Sheng-yu, WANG Fei, LI Bo, CAO Wen-li, LIU Qian-ying, CHEN Dong-jin, SHI Lian, WANG Xin, LI You-lun, YANG Shang-peng, PENG Zhang-li, WU Chao, OUYANG Bing, WANG Fu-rong, LI Po, WU Xiang, XI Xiu-e, LENG Xue-yan, ZHANG Hai-qing, LI Hua, LI Juan, YANG Cheng-qing, ZHANG Peng, CUI Hong-zhe, XIE Li, LIU Yu-hong, LI Liang, GAO Wei-wei. Treatment effect analysis of the optimized regimen for re-treated drug-susceptible pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 328-334. |
[5] | ZHANG Li-jie, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340. |
[6] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui, LI Cheng-cheng. Analysis of CT features of drug-resistant pulmonary tuberculosis with cavity [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 341-345. |
[7] | YU Shan, LI Zhi-ming, XU Chun-xia, WANG Tao. Analysis of risk factors associated with false negative results of interferon-gamma release assays on peripheral blood from tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 346-351. |
[8] | LIU Ting, WANG Liang, YANG Mei. The study on the anti-tuberculosis activity of polymorphonuclear cell from peripheral blood of patients with multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 352-356. |
[9] | ZHANG Chen-chen, TAN Wei-guo, GUO Hui-xin, HUANG Xin-chun, CHEN Yan-mei, WEI Wen-jing. The effect of Mycobacterium tuberculosis infection on sputum flora structure [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 357-363. |
[10] | BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369. |
[11] | WANG Huan, SHEN Xin, CHEN Jing, XIA Zhen, XU Biao, YUAN Zheng-an. Analysis of the epidemiological characteristics of pulmonary tuberculosis among migrants in Shanghai from 2008 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 370-377. |
[12] | MA Zhi-tao, WANG Na, LYU Yang, HU Wei-hong, CHEN Chang, HE Fan, SHEN Xin, LIU Xiao-feng. The research on psychological status of pulmonary tuberculosis patients and influencing factors in Baoshan District, Shanghai [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 378-384. |
[13] | LI Zhi-hong, GU Kan-kai, YAO Jing, ZHANG Huai-qing, HAN Zhi-ying, SHEN Xin, CHEN Jing, SHEN Bing. Analysis of screening of close contacts of a tuberculosis patient in a kindergarten in downtown Shanghai [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 385-390. |
[14] | LIU Zhen-jiang, LI Guan-zhen, OU Xi-chao. Analysis on the therapeutic effect and influencing factors of initial treated smear-positive pulmonary tuberculosis patients in Kashgar Prefecture from 2016 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 391-397. |
[15] | ZHOU Shuang, CHEN Nan, ZHU Kun, JIANG Hui, YANG Lei, DU Jian. Investigation of the experience of tuberculosis patients for follow up using the internet platform [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 398-403. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||